Historical record - last NADAC publication: 8/22/2013
Product Information
TAZICEF 2 GRAM VIAL is a generic product labeled by Hospira Inc., priced at $9.5080 per EA under NDC 00409508411. Its NADAC has been published 42 times since Nov 28, 2013.
Strength
2 g/1
Manufacturer
Hospira Inc.NDC
00409508411
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
8/22/2013
Active Ingredients
CEFTAZIDIMEApproval Type
Generic (ANDA)
FDA Application
ANDA062662On Market Since
12/16/2005
Pharmacological Classes
Price Statistics
The NADAC for TAZICEF 2 GRAM VIAL has been published 42 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5080 per EA |
|---|---|
| All-time high | $9.5080 (Sep 10, 2014) |
| All-time low | $9.5080 (Nov 28, 2013) |
| Median price | $9.5080 |
| Average price | $9.5080 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 42 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CEFTAZIDIME market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TAZICEF 2 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TAZICEF 2 GRAM VIAL, manufactured by Hospira Inc., is $9.5080 per EA (NDC 00409508411), effective Sep 10, 2014.
How has the price of TAZICEF 2 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for TAZICEF 2 GRAM VIAL has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAZICEF 2 GRAM VIAL?
Since Nov 28, 2013, the NADAC for TAZICEF 2 GRAM VIAL has ranged from a low of $9.5080 (Nov 28, 2013) to a high of $9.5080 (Sep 10, 2014), with a median of $9.5080 per EA.
Are there cheaper alternatives to TAZICEF 2 GRAM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TAZICEF 2 GRAM VIAL, so no direct lower-cost alternative is listed.
Who manufactures TAZICEF 2 GRAM VIAL?
TAZICEF 2 GRAM VIAL (NDC 00409508411) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification